Dichloromethane → Clopidogrel

HRID 1673061노트

반응식

HRID 1673061 반응식
[CH3:1][O:2][C:3]([C@@H:5]([N:13]1[CH2:18][C:17]2[CH:19]=[CH:20][S:21][C:16]=2[CH2:15][CH2:14]1)[C:6]1[C:11]([Cl:12])=[CH:10][CH:9]=[CH:8][CH:7]=1)=[O:4].Cl.C(Cl)Cl.C(=O)([O-])[O-].[K+].[K+]>O>[CH3:1][O:2][C:3]([C@@H:5]([N:13]1[CH2:18][C:17]2[CH:19]=[CH:20][S:21][C:16]=2[CH2:15][CH2:14]1)[C:6]1[CH:7]=[CH:8][CH:9]=[CH:10][C:11]=1[Cl:12])=[O:4]

참가 물질

5

실험 절차

Under the protection of nitrogen gas, clopidogrel hydrochloride (7.15 g) was introduced into methylene dichloride (100 ml) in a 250 ml flask under stirring and cooling with ice water. Then a solution of potassium carbonate (2.5 g) in de-ionized water (30 ml) was added drop by drop into the flask and it was stirred for one hour. The pH value of the upper aqueous phase was kept over 9. The lower organic phase was separated and the aqueous phase was extracted with methylene dichloride (50 ml). The organic phases were combined and dried over sodium sulfate and then concentrated to obtain a free clopidogrel base.

후처리

  1. stirringwas stirred for one hour
  2. customThe lower organic phase was separated
  3. extractionthe aqueous phase was extracted with methylene dichloride (50 ml)
  4. dry with materialdried over sodium sulfate
  5. concentrationconcentrated

출처 및 근거

ORD 기록
ord-da6f826fad2546f5a6addd043d44c31c
출처 데이터셋
uspto-grants-2011_08
특허 번호
US07999106B2

반응 노트

불러오는 중…